About the Authors
- Agnes Gardet
-
* E-mail: dania.rabah@biogen.com (DR); agnes.gardet@biogen.com (AG)
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Wei C. Chou
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Taylor L. Reynolds
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Diana B. Velez
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Kai Fu
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Julia M. Czerkowicz
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Jeffrey Bajko
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Ann M. Ranger
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Normand Allaire
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Hannah M. Kerns
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Sarah Ryan
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Holly M. Legault
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Robert W. Dunstan
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Robert Lafyatis
-
Affiliation Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, United States of America
- Matvey Lukashev
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Joanne L. Viney
-
Affiliation Biogen, Cambridge, Massachusetts, United States of America
- Jeffrey L. Browning
-
Affiliation Boston University School of Medicine, Department of Microbiology, Boston, United States of America
- Dania Rabah
-
* E-mail: dania.rabah@biogen.com (DR); agnes.gardet@biogen.com (AG)
Affiliation Biogen, Cambridge, Massachusetts, United States of America
Competing Interests
AG, WCC, TLR, DBV, KF, JMC, JB, AMR, NA, HMK, SR, HML, RWD, ML, JLV, JLB and DR were employees of Biogen at the time of the study. RL receives grant support from Shire, Elpidera, Inception, Regeneron, Prism, Genentech, Biogen, Pfizer and Bristol Meyers Squibb and consulting fees from Merck and Momenta. The authors confirm that the authors’ affiliations to companies does not alter their adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: AG JLB DR BL. Formal analysis: AG WCC TLR DVB KF JMC ML DR. Investigation: WCC DBV KF JMC JB HMK HML. Methodology: AG WCC TLR DBV KF JMC JB AMR NA HMK SR HML RWD DR. Project administration: DR. Supervision: AG JV DR. Visualization: AG WCC TLR DR. Writing – original draft: AG DR. Writing – review & editing: AG TLR RL JV JLB DR.